Jean Qiu joined the intellectual property transaction group of Ropes & Gray’s Shanghai office as an international associate in 2019. Jean represents clients on business and intellectual property transactions, including technology transfer and technology licensing.
Before joining Ropes & Gray, Jean practiced both IP litigation and prosecution matters, and represented companies in a wide range of industries, including private equity, branded consumer products, manufacturing, chemistry, life sciences, pharmaceuticals and medical devices.
Jean obtained a bachelor degree in Biotechnology in China and J.D. degree in the United States. Jean also passed the Chinese bar exam.
- Assisted Innovent Biologics Inc., a leading bio-pharmaceuticals company based in China, to out-license its biologics to different U.S. partners.
- Advised a U.S.-based biopharmaceutical company in its Chinese joint venture’s in-license activities.
- Advised multinational companies regarding IP enforcement matters in the PRC.
- Conducted IP and data privacy due diligence for PE clients, assisted the clients with diligence issues and advised clients caveats and risked mitigation strategies.
- Assisted pharmaceutical companies to formulate IP policies and reward and remuneration policies in the PRC.
- Co-author, “New Development of the double-track protection system for innovative drugs,” China Food & Drug Administration Magazine (June 2018)
- Co-author, “A Brief Comment on the Special Approval Process for Innovative Medical Devices (Revised Draft for Consultation),” LexisNexis (May 29, 2018)
- Co-author, “Healthcare Enforcement & Litigation for China,” Getting the deal through (October, 2018)